These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15906176)

  • 21. Molecular dynamics simulation of amorphous indomethacin.
    Xiang TX; Anderson BD
    Mol Pharm; 2013 Jan; 10(1):102-14. PubMed ID: 23116319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of amorphous solid dispersions using 2D solid-state NMR and (1)H T(1) relaxation measurements.
    Pham TN; Watson SA; Edwards AJ; Chavda M; Clawson JS; Strohmeier M; Vogt FG
    Mol Pharm; 2010 Oct; 7(5):1667-91. PubMed ID: 20681586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in dynamics of the glass-forming pharmaceutical nifedipine in binary mixtures with octaacetylmaltose.
    Kaminska E; Tarnacka M; Kaminski K; Ngai KL; Paluch M
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):185-91. PubMed ID: 26428937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of molecular mobility on the physical stability of amorphous pharmaceuticals in the supercooled and glassy States.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2014 Sep; 11(9):3048-55. PubMed ID: 25105216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
    Amharar Y; Curtin V; Gallagher KH; Healy AM
    Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.
    Mao C; Chamarthy SP; Pinal R
    Pharm Res; 2006 Aug; 23(8):1906-17. PubMed ID: 16858653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the effects of pharmaceutical processing upon solid-state NMR relaxation times and implications to solid-state formulation stability.
    Lubach JW; Xu D; Segmuller BE; Munson EJ
    J Pharm Sci; 2007 Apr; 96(4):777-87. PubMed ID: 17238201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.
    Tong P; Zografi G
    Pharm Res; 1999 Aug; 16(8):1186-92. PubMed ID: 10468018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.
    Moura Ramos JJ; Diogo HP
    Curr Drug Deliv; 2017; 14(1):91-98. PubMed ID: 27160253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow coloration phenomena of incorporated indomethacin into folded sheet mesoporous materials.
    Tanabe S; Higashi K; Umino M; Limwikrant W; Yamamoto K; Moribe K
    Int J Pharm; 2012 Jun; 429(1-2):38-45. PubMed ID: 22446085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A solid-state NMR study of phase structure, molecular interactions, and mobility in blends of citric acid and paracetamol.
    Schantz S; Hoppu P; Juppo AM
    J Pharm Sci; 2009 May; 98(5):1862-70. PubMed ID: 18802950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T
    Okada K; Hirai D; Hayashi Y; Kumada S; Kosugi A; Onuki Y
    Chem Pharm Bull (Tokyo); 2019; 67(6):580-586. PubMed ID: 31155564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers.
    Semjonov K; Kogermann K; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
    Eur J Pharm Sci; 2017 Jan; 97():237-246. PubMed ID: 27890595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13 C solid-state nuclear magnetic resonance using 1 H T1rho relaxation time.
    Nasu M; Nemoto T; Mimura H; Sako K
    J Pharm Sci; 2013 Jan; 102(1):154-61. PubMed ID: 23147444
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Okada K; Hirai D; Kumada S; Kosugi A; Hayashi Y; Onuki Y
    J Pharm Sci; 2019 Jan; 108(1):451-456. PubMed ID: 30267784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A stable amorphous statin: solid-state NMR and dielectric studies on dynamic heterogeneity of simvastatin.
    Nunes TG; Viciosa MT; Correia NT; Danède F; Nunes RG; Diogo HP
    Mol Pharm; 2014 Mar; 11(3):727-37. PubMed ID: 24499472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing beta relaxation in pharmaceutically relevant glasses by using DSC.
    Vyazovkin S; Dranca I
    Pharm Res; 2006 Feb; 23(2):422-8. PubMed ID: 16388410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
    Aso Y; Yoshioka S; Kojima S
    J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.